I. Introduction
Chronically viable neuroelectronic interfaces are required for neuromodulation therapy and fundamental neuroscience research, but most available tools have short functional lifetimes due in part to the body's immune response [1], [2]. Soft, flexible microelectrode arrays (MEA) are an emerging technology that offer a means to mitigate the immune response by replacing silicon and metal-based electrodes with polymers as a softer alternative [3]–[8]. However, there are few polymer MEAs (pMEA) available to researchers, and fewer still which meet the range of needs of current neuroscience research.